SARS-CoV-2 Peptide Microarray Analysis service

Wuhan, China, had pneumonia of unknown etiology in December 2019. Unbiased sequencing was used to identify a previously unidentified beta-coronavirus in pneumonia patient samples. This unidentified coronavirus is identified as SARS-CoV-2 following a sequence of sequencing and sample analysis. In order to support the research initiatives of our international clients, Creative Biolabs is dedicated to provide premium biological products and tailored solutions. Owing to the severe situation in the globe, particularly in China, we provide peptide microarray analysis services for SARS-CoV-2 to assist researchers in their efforts to find and develop new drugs for the virus.

Check more details: SARS-CoV-2 Peptide Microarray Analysis service